PatrickThomasGriffinMD

Hematologic Oncology

Hematology and Medical Oncology

Dr. Griffin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6500 Harris Pkwy
Fort Worth, TX 76132
Phone+1 817-263-2600

Fax+1 817-263-2805

University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2010 - 2013
McGovern Medical School at UTHealthClass of 2010

Abstract Achievement Award American Society of Hematology 56th Annual Meeting, 2014
Doctor's Dilemma Champion Texas Chapter of the American College of Physicians Annual Meeting, 2012
Abstract Achievement Award American Society of Hematology 53th Annual Meeting, 2011
Member Alpha Omega Alpha, 2010
Join now to see all

PubMed

151 citations
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.
Steffan T. Nawrocki, Patrick T. Griffin, Kevin R. Kelly, Jennifer S. Carew
Expert Opinion on Investigational Drugs. 2012-09-20
39 citations
A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma
Patrick T. Griffin, Viet Q. Ho, William J. Fulp, Taiga Nishihori, Kenneth H. Shain
Cancer. 2015-10-15
22 citations
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.
Patrick T. Griffin, Rami S. Komrokji, Carlos M. de Castro, David A. Rizzieri, Magda Melchert
American Journal of Hematology. 2015-09-01

Books/Book Chapters

Handbook of Hematologic Malignancies
Chapter: Multiple Myeloma
Page 154 - 160Patrick Griffin and Rachid BazEditors: David Sallman, Ateefa Chaudhury, Johnny Nguyen, Ling Zhang, Alan List..Demos Medical, New York2017

Abstracts/Posters

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index
Griffin PT, Dalia S, Shah BD, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
Is There a Preferred Infusional Regimen for Patients with Relapsed/Refractory Multiple Myeloma?
Griffin PT, Ho VQ, Fulp W, et al, American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, Retrospective Analysis
Griffin PT, Chavez JC, Bello CM, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
The Investigational Multi-Targeted Kinase Inhibitor TAK-901 Antagonizes Acute Myeloid Leukemia Pathogenesis: Results of Preclinical Studies
Griffin, P., S. T. Nawrocki, et al, American Society of Hematology 53th Annual Meeting Oral Presentation, San Diego, CA, 12/2011
Join now to see all